Radiotherapy for single station N2 NSCLC. - Wikidata - awgldk - TriplyDB

Radiotherapy for single station N2 NSCLC.

Radiotherapy for single station N2 NSCLC.

http://www.wikidata.org/entity/Q38390158

about

Radiotherapy for single station N2 NSCLC.

http://www.wikidata.org/entity/Q38390158

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Radiotherapy for single station N2 NSCLC.

@en

type

label

Radiotherapy for single station N2 NSCLC.

@en

prefLabel

Radiotherapy for single station N2 NSCLC.

@en

P1433

Q38390158-54B0307F-C247-454D-BCC0-EF2B0DD105A6

P1476

Q38390158-0D2238AE-0F8B-4117-99D5-66BE6FBC6BD5

P2093

Q38390158-2BA6804E-4B15-41F1-8510-183483EDE60D

P2860

Q38390158-01398E0E-1534-40D2-9504-3F7CC7638CD6

Q38390158-0BD5C0D7-938C-47C2-903F-D47892F5BE51

Q38390158-0C48F3A3-573C-43D9-A1D2-5EE469FBEF3C

Q38390158-11ABB1C0-A8DF-44E1-B4A9-E9B0B6E8AF8D

Q38390158-44B93817-516A-46B3-BC40-210F4F7E77E1

Q38390158-4CF63EE0-351D-4E15-B4FC-F81E4E94EC02

Q38390158-7827016E-4D93-4061-8044-46DE4942C712

Q38390158-7872D59F-FC18-40D0-A892-B40E864F1FBA

Q38390158-7F7DE3FD-D01A-4CE2-8520-C73F55F341F2

Q38390158-9A7C83B3-D1D6-473C-AE2E-AA60799B59CB

P304

Q38390158-098C3217-780E-4B53-99D3-8BF2EB6BFC82

P31

Q38390158-549944D1-C75D-468A-B63E-7F373CEF5ADC

P356

Q38390158-75FB6A31-2201-4123-A923-A9342EC89F73

P433

Q38390158-7FF36B34-6C30-4692-B5B8-A82D650DA74A

P478

Q38390158-458CEC14-88BA-449B-BFF0-9928B4FCBED9

P577

Q38390158-1C916294-825C-428D-8CE3-38DA38869745

P698

Q38390158-721F7E38-A40C-46B9-B18A-B241499C99C4

P932

Q38390158-49D9567E-7BB3-4883-8AA2-0CAA46F8229A

P356

J.ISSN.2218-6751.2014.07.04

P1433

Translational lung cancer research

P1476

Radiotherapy for single station N2 NSCLC.

@en

P2093

Jan P van Meerbeeck

http://www.w3.org/2001/XMLSchema#string

P2860

Postoperative radiotherapy for non-small cell lung cancer

Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial.

Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database.

Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial.

Postoperative radiotherapy in stage II or IIIA completely resected non-small cell lung cancer: a systematic review and practice guideline.

Localized non-small cell lung cancer: adjuvant radiotherapy in the era of effective systemic therapy.

What to do with "Surprise" N2?: intraoperative management of patients with non-small cell lung cancer.

Treatment of stage III non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: a meta-analysis.

Lymph node ratio may predict the benefit of postoperative radiotherapy in non-small-cell lung cancer.

P304

234-237

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3978/J.ISSN.2218-6751.2014.07.04

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2014-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25806305

http://www.w3.org/2001/XMLSchema#string

P932

4367705

http://www.w3.org/2001/XMLSchema#string